MAP LC3β2 Inhibitors

MAP LC3β2 inhibitors represent a class of chemical compounds that hold significance in the field of cellular biology, particularly in the context of autophagy regulation. LC3β2, which stands for Microtubule-associated protein 1A/1B-light chain 3 beta-2, is a specific isoform of LC3, a protein that plays a pivotal role in the process of autophagy. Autophagy is a highly conserved cellular mechanism responsible for degrading and recycling cellular components, including organelles and proteins, to maintain cellular homeostasis. LC3 proteins, including LC3β2, are key components of the autophagy machinery and are crucial for the formation and maturation of autophagosomes, which are double-membrane vesicles that engulf cellular cargo destined for degradation.

MAP LC3β2 inhibitors are designed to modulate the activity of LC3β2, often by interfering with its interaction with other autophagy-related proteins or by disrupting its post-translational modifications. These inhibitors can impact the autophagy process by affecting the formation of autophagosomes and the subsequent autophagic flux. Researchers employ MAP LC3β2 inhibitors as valuable tools to investigate the specific functions of LC3β2 in autophagy regulation and cellular quality control.